|
Each ml
contains:
Composition:
Methylergometrine
Maleate IP….................................….0.2 mg
Water for
injection
IP…............................................................q.s.
Indications:
Oral:
Post-partum, haemorrhage, uterine atony, menorrhagia,
menopausal haemorrhage, stubborn & prolonged uterine
inertia. In association with caesarean section,
following abortion, lochiometra, puerperal bleeding.
Description:
Methylergonovine maleate (Methergine®), an ergot
derivative with vasoconstrictive properties, has been
cited as an effective treatment for vascular headaches.
Few studies are available to support its use in headache
management. An uncontrolled pilot study of 20 episodic
cluster headache patients confirmed its effectiveness
and tolerability as an adjunct cluster headache
prophylactic. Decreased headache frequency was reported
by 19 of 20 patients (95%), and 15 of 20 patients (75%)
reported decreased intensity of headaches within 1 week
of initiating therapy. A review of methylergonovine's
pharmacokinetic, molecular, and tolerability profile
clarifies its mechanisms and clinical role in headache
management.
Dosage : As
per the physician’s advice.
Presentations :
MRP Retailer Stockiest
25.00 20.00 18.00
|
